ID   HCC2429 BL
AC   CVCL_V989
SY   HCC-2429BL; HCC2429BL; BL2429; Hamon Cancer Center 2429 BL
DR   Wikidata; Q54881657
RX   PubMed=10944559;
RX   PubMed=15994877;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5132 ! HCC2429
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 11
//
RX   PubMed=10944559; DOI=10.1093/jnci/92.16.1355;
RA   Dang T.P., Gazdar A.F., Virmani A.K., Sepetavec T., Hande K.R.,
RA   Minna J.D., Roberts J.R., Carbone D.P.;
RT   "Chromosome 19 translocation, overexpression of Notch3, and human lung
RT   cancer.";
RL   J. Natl. Cancer Inst. 92:1355-1357(2000).
//
RX   PubMed=15994877; DOI=10.1136/jmg.2004.029686; PMCID=PMC1736105;
RA   Haruki N., Kawaguchi K.S., Eichenberger S., Massion P.P., Gonzalez A.,
RA   Gazdar A.F., Minna J.D., Carbone D.P., Dang T.P.;
RT   "Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S
RT   phase in vitro.";
RL   J. Med. Genet. 42:558-564(2005).
//